Literature DB >> 34135344

Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity.

Simon Fish1,2, Foteini Christidi3, Efstratios Karavasilis4, Georgios Velonakis4, Nikolaos Kelekis4, Christoph Klein5,6,7, Nicholas C Stefanis2, Nikolaos Smyrnis8,9.   

Abstract

Chronic cannabis use and schizophrenia are both thought to affect reward processing. While behavioural and neural effects on reward processing have been investigated in both conditions, their interaction has not been studied, although chronic cannabis use is common among these patients. In the present study eighty-nine participants divided into four groups (control chronic cannabis users and non-users; schizophrenia patient cannabis users and non-users) performed a two-choice decision task, preceded by monetary cues (high/low reward/punishment or neutral), while being scanned using functional magnetic resonance imaging. Reward and punishment anticipation resulted in activation of regions of interest including the thalamus, striatum, amygdala and insula. Chronic cannabis use and schizophrenia had opposing effects on reward anticipation sensitivity. More specifically control users and patient non-users showed faster behavioural responses and increased activity in anterior/posterior insula for high magnitude cues compared to control non-users and patient users. The same interaction pattern was observed in the activation of the right thalamus for reward versus punishment cues. This study provided evidence for interaction of chronic cannabis use and schizophrenia on reward processing and highlights the need for future research addressing the significance of this interaction for the pathophysiology of these conditions and its clinical consequences.

Entities:  

Year:  2021        PMID: 34135344     DOI: 10.1038/s41537-021-00163-2

Source DB:  PubMed          Journal:  NPJ Schizophr        ISSN: 2334-265X


  39 in total

1.  Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards.

Authors:  Moria J Smoski; Alison Rittenberg; Gabriel S Dichter
Journal:  Psychiatry Res       Date:  2011-11-10       Impact factor: 3.222

2.  Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study.

Authors:  Stanley Zammit; Peter Allebeck; Sven Andreasson; Ingvar Lundberg; Glyn Lewis
Journal:  BMJ       Date:  2002-11-23

3.  Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study.

Authors:  Josiane Bourque; Adrianna Mendrek; Myriam Durand; Nadia Lakis; Olivier Lipp; Emmanuel Stip; Pierre Lalonde; Sylvain Grignon; Stéphane Potvin
Journal:  Psychiatry Res       Date:  2013-07-30       Impact factor: 3.222

4.  Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users.

Authors:  Liam Nestor; Robert Hester; Hugh Garavan
Journal:  Neuroimage       Date:  2009-07-23       Impact factor: 6.556

5.  Chronic effects of cannabis use on the human reward system: an fMRI study.

Authors:  Hendrika H van Hell; Matthijs Vink; Lindsey Ossewaarde; Gerry Jager; René S Kahn; Nick F Ramsey
Journal:  Eur Neuropsychopharmacol       Date:  2010-01-12       Impact factor: 4.600

6.  Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia.

Authors:  Henrik Walter; Hannes Kammerer; Karel Frasch; Manfred Spitzer; Birgit Abler
Journal:  Psychopharmacology (Berl)       Date:  2009-06-12       Impact factor: 4.530

7.  Alterations of monetary reward and punishment processing in chronic cannabis users: an FMRI study.

Authors:  Björn Enzi; Silke Lissek; Marc-Andreas Edel; Martin Tegenthoff; Volkmar Nicolas; Norbert Scherbaum; Georg Juckel; Patrik Roser
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  Does incentive-elicited nucleus accumbens activation differ by substance of abuse? An examination with adolescents.

Authors:  Hollis C Karoly; Angela D Bryan; Barbara J Weiland; Andrew Mayer; Andrew Dodd; Sarah W Feldstein Ewing
Journal:  Dev Cogn Neurosci       Date:  2015-05-23       Impact factor: 6.464

9.  Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.

Authors:  Musa Basseer Sami; Sagnik Bhattacharyya
Journal:  J Psychopharmacol       Date:  2018-03-29       Impact factor: 4.153

10.  Activation in the VTA and nucleus accumbens increases in anticipation of both gains and losses.

Authors:  R McKell Carter; Jeff J Macinnes; Scott A Huettel; R Alison Adcock
Journal:  Front Behav Neurosci       Date:  2009-08-27       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.